Functional Medicine · Hormonal Health

The Journal

by Dr. Natasha Ryan, ND

Hormone Therapy · Autoimmunity

HRT and Autoimmune Disease: What Women With Hashimoto's Should Know

Women develop autoimmune disease far more often than men, and many conditions shift around menopause. So when headlines connect hormone therapy to autoimmune risk, the women most likely to worry are those with Hashimoto's, celiac disease, psoriasis or a strong family history of autoimmunity who are weighing HRT for perimenopause symptoms.

Here's what the research actually says, what it doesn't say, and what I'd want you to do with it.

What the new study found

At The Menopause Society's 2026 annual meeting, researchers from Drexel University presented a large records-based study comparing two common HRT regimens: estrogen alone versus estrogen plus a progestogen. After matching, each group had 54,692 women aged 45 to 70. Women who already had an autoimmune disease were excluded, so the study looked at new diagnoses only.

Over roughly three and a half years, new autoimmune diagnoses occurred in 4.9% of women on estrogen alone and 4.5% of women on estrogen plus a progestogen. That's a small relative difference. The gap showed up for some conditions, including lupus, rheumatoid arthritis, psoriasis, psoriatic arthritis, multiple sclerosis and lichen sclerosus, but not uniformly across all of them.

The same research group reported in 2025 that women using hormone therapy had a higher rate of autoimmune diagnoses than non-users, though the absolute increase was small and varied by condition.

What it doesn't mean

This is the part the headlines skip. These are observational studies built from electronic health records. They can show an association. They can't show cause.

  • Women who choose HRT may differ from those who don't. They may see doctors more often, get more testing, and get diagnosed with things that were already brewing.
  • Autoimmune diagnoses are messy in billing codes. Experts quoted on the 2026 study pointed out that coded diagnoses don't always reflect real disease.
  • It doesn't tell us about disease course. The study looked at new diagnoses, not whether existing conditions got better or worse.

The researchers themselves said the findings shouldn't change prescribing on their own, and that clinicians shouldn't add a progestogen just to lower autoimmune risk. The Menopause Society's medical director summed it up as awareness rather than alarm.

The interesting question the study raises is whether progesterone has a protective, immune-calming effect. Progesterone does have immunomodulating properties. That's a hypothesis worth watching, not a conclusion.

The thyroid detail that matters more day to day

If you have Hashimoto's and take levothyroxine, there's a much better established interaction you should know about. Oral estrogen raises thyroxine-binding globulin, a protein that holds thyroid hormone in the blood. In a classic study of postmenopausal women, those on thyroid replacement saw free T4 fall and TSH rise after starting oral estrogen, and some needed a higher thyroid dose.

Transdermal estrogen (patch, gel or spray) has much less effect on these binding proteins because it skips the first pass through the liver. That's one reason the route matters for women with thyroid disease.

In practice, this means:

  • Recheck TSH and free T4 about six to eight weeks after starting or changing estrogen.
  • Expect that your thyroid dose may need adjusting, especially with oral estrogen.
  • Don't assume new fatigue or weight gain on HRT is "just the hormones." It may be your thyroid.

A functional medicine approach for women with autoimmunity

Hormones are powerful immune signals, but they're one input among many. When a woman with autoimmunity comes to me in perimenopause, I look at the whole system that drives immune activity:

  • Gut barrier and microbiome. Intestinal permeability and dysbiosis are common threads in autoimmune disease. Food sensitivities, low stomach acid and low fiber intake all play in.
  • Vitamin D. Low vitamin D is common in autoimmune conditions. I test it rather than guess.
  • Selenium and iodine balance. Both matter for the thyroid, and more is not always better, especially with iodine in Hashimoto's.
  • Blood sugar and inflammation. Insulin resistance rises in perimenopause and feeds inflammation.
  • Sleep and stress load. Night sweats and 3 a.m. waking wreck sleep, and poor sleep drives immune dysregulation. Treating the symptoms can be part of calming the immune system.
  • Antibody trends. TPO and thyroglobulin antibodies give a rough read on how active the process is over time.

Should you avoid HRT if you have Hashimoto's?

Based on what we know today, no, not on these findings alone. HRT is still the most effective treatment for hot flashes and the sleep disruption that comes with them, and untreated symptoms carry their own costs. What these studies support is a more personal approach: choosing the route and regimen thoughtfully, monitoring thyroid labs, tracking symptoms and antibodies, and working on the foundations that drive immune activity in the first place.

If you have an autoimmune condition, the decision deserves a real conversation that includes your full history, your family history and your goals.

Women with Hashimoto's need a plan that looks at thyroid and hormones together. That's how I approach menopause care.

If you're managing Hashimoto's or another autoimmune condition, see my functional medicine care for autoimmune conditions.

References

  1. Jiang X, et al. Incident autoimmune disease risk among women receiving systemic estrogen-only versus estrogen-progestogen menopausal hormone therapy. Presented at: The Menopause Society 2026 Annual Meeting; October 20-24, 2026; San Diego, CA. Reported in Healio, Oct 23, 2026 (conference presentation, not yet peer-reviewed)
  2. Syed A, Jiang XD. Association of hormone therapy with autoimmune disease risk in postmenopausal women: a TriNetX-based analysis. Presented at: The Menopause Society 2025 Annual Meeting; October 21-25, 2025; Orlando, FL. The Menopause Society press release
  3. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743-1749. PMID 11396440